Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177903 | SCV000229862 | benign | not specified | 2014-12-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000177903 | SCV000307971 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000177903 | SCV000519702 | benign | not specified | 2016-04-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000556508 | SCV000651102 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000177903 | SCV003929231 | benign | not specified | 2023-04-10 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003486731 | SCV004240665 | benign | Cardiomyopathy | 2023-05-16 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000177903 | SCV001925742 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701779 | SCV001929075 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000177903 | SCV001956974 | benign | not specified | no assertion criteria provided | clinical testing |